Miist Therapeutics, founded in 2019, is making waves in the Health Care and Pharmaceutical industries with their commitment to developing effective addiction treatments. With the slogan, "Addiction Treatments That Work," the company is initially targeting the smoking epidemic—an area where traditional quitting aids have largely failed. The team is dedicated to putting innovative solutions into every smoker's pocket to address the significant health risks associated with cigarette addiction.
Headquartered in the United States, Miist Therapeutics positions itself as a leader in transforming addiction treatment. They secured a $50.00K Seed Round investment on 19 December 2022, backed by notable investors such as StartUp Health and ZeroTo510. This financial support underscores the confidence the investment community has in Miist's unique approach to a longstanding public health challenge.